Regulation of innate lymphocyte function by Zbtb32
Zbtb32 对先天淋巴细胞功能的调节
基本信息
- 批准号:8869820
- 负责人:
- 金额:$ 16.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-05 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergic DiseaseAntiviral ResponseAutoimmune DiseasesAutoimmunityB-LymphocytesCD4 Positive T LymphocytesCell LineageCell ProliferationCell physiologyCellsChIP-seqCo-ImmunoprecipitationsCommon Lymphoid ProgenitorComplexDataDependencyDevelopmentDiagnostic testsDiseaseFacultyFamilyGene TargetingGoalsHelminthsHumanHypersensitivityImmuneImmune responseImmune systemImmunityInfectionInflammationInfluenzaInterleukin 2 Receptor GammaInvestigationK22 AwardKnowledgeLinkLungLymphocyteLymphocyte FunctionLymphocyte SubsetLymphoid CellMalignant NeoplasmsMediator of activation proteinMicrobeMolecularMusNatural Killer CellsOrganPathway interactionsPlayPopulationPositioning AttributeRegulationReportingResearchResearch PersonnelResearch ProposalsResourcesRoleSignal PathwaySkinStem cellsStructure of germinal center of lymph nodeT-LymphocyteTestingTimeTissuesTranscription Repressor/CorepressorVaccinesViralVirusVirus DiseasesZNF145 geneZinc Fingersadaptive immunityantiviral immunitycareercytokineeffective therapyfascinategene repressionhuman diseasein vivonovelnovel therapeuticspathogenpost-doctoral trainingprogramspublic health relevancereceptorrepairedresearch studyresponsetenure tracktranscription factor
项目摘要
DESCRIPTION (provided by applicant): The immune system responds to infection with a complex interplay of immune cells and secreted factors aimed at eliminating the intruding pathogen and repairing damaged tissue. Innate lymphocytes, which include NK cells, NKT cells, T cells, and the newly discovered innate lymphoid cells (ILCs), are a fascinating and relatively understudied subset of immune cells that function at the interface of innate and adaptive immune responses. My goal is to establish independent research program focused on understanding the molecular pathways that regulate effector responses by innate lymphocytes during infection.
During my postdoctoral training, I discovered a novel signaling pathway involving the transcription factors Zbtb32 and Blimp-1 that critically regulates anti-viral responses by NK cells1. As an independent faculty researcher, I plan to continue my investigation of how Zbtb32 regulates anti-pathogen responses by innate lymphocytes. Specifically, the studies proposed in this K22 application aim to: (1) determine whether Zbtb32 and Blimp-1 physically interact in NK cells and whether Zbtb32 influences the suite of genes targeted by Blimp- 1 for transcriptional repression; and (2) explore whether Zbtb32 regulates anti-viral immune responses by Type 2 ILCs during influenza infection in vivo.
Given the remarkable range of diseases regulated by innate lymphocytes, including viral, bacterial, and helminth infections, and allergic and autoimmune diseases, the proposed studies will have important applications in the development of new therapies, vaccines, and diagnostic tests for a wide variety of human illnesses. Moreover, support from this K22 award would provide me with key time and resources to successfully transition into a tenure-track faculty position and to acquire the knowledge and data I will need to launch a productive and sustainable independent research career.
描述(由适用提供):免疫系统应对免疫细胞的复杂相互作用和旨在消除侵入病原体和修复损坏的组织的分泌因子的感染做出反应。先天淋巴细胞,包括NK细胞,NKT细胞,t细胞和新发现的先天淋巴样细胞(ILC),是一种令人着迷的和相对理解的免疫细胞的子集,可在先天和适应性免疫调查的界面起作用。我的目标是建立独立的研究计划,专注于了解在感染过程中先天淋巴细胞调节效应子反应的分子途径。
在博士后训练中,我发现了一种新颖的信号通路涉及转录因子ZBTB32和Blimp-1,该因子严格调节NK细胞的抗病毒反应1。作为一名独立的教师研究员,我计划继续对ZBTB32如何调节先天淋巴细胞的抗病原体反应的投资。具体而言,在此K22应用中提出的研究目的是:(1)确定ZBTB32和Blimp-1是否在NK细胞中物理相互作用以及ZBTB32是否影响Blimp-1靶向转录表达的基因套件; (2)探索ZBTB32是否在体内影响期间按2型ILC调节抗病毒免疫反应。
鉴于由先天淋巴细胞调节的疾病范围很大,包括病毒,细菌和头盔感染,以及过敏性和自身免疫性疾病,因此拟议的研究将在开发新疗法,疫苗,疫苗和诊断诊断性的各种人类疾病方面具有重要应用。此外,该K22奖的支持将为我提供关键的时间和资源,以成功地过渡到终身教师职位,并获得我将需要开展富有成效且可持续的独立研究职业的知识和数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aimee Melissa Beaulieu其他文献
Aimee Melissa Beaulieu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aimee Melissa Beaulieu', 18)}}的其他基金
Birc5 as a regulator of NK cell development and immune function
Birc5 作为 NK 细胞发育和免疫功能的调节剂
- 批准号:
10311057 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
Innate Immune Mechanisms at the Maternal-Fetal Interface in Normal and Superovulatory Pregnancy
正常和超排卵妊娠母胎界面的先天免疫机制
- 批准号:
10447103 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
Birc5 as a regulator of NK cell development and immune function
Birc5 作为 NK 细胞发育和免疫功能的调节剂
- 批准号:
10066361 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
Innate Immune Mechanisms at the Maternal-Fetal Interface in Normal and Superovulatory Pregnancy
正常和超排卵妊娠母胎界面的先天免疫机制
- 批准号:
10681406 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
Birc5 as a regulator of NK cell development and immune function
Birc5 作为 NK 细胞发育和免疫功能的调节剂
- 批准号:
10543978 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
Innate Immune Mechanisms at the Maternal-Fetal Interface in Normal and Superovulatory Pregnancy
正常和超排卵妊娠母胎界面的先天免疫机制
- 批准号:
10222493 - 财政年份:2019
- 资助金额:
$ 16.2万 - 项目类别:
相似国自然基金
基于社会生态理论的儿童过敏性疾病及其健康影响的多维风险因素识别、动态预警及健康管理策略研究
- 批准号:72374059
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
空气污染与食物过敏原早期暴露对儿童第二波过敏性疾病的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:82260324
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
治疗过敏性疾病相关激酶靶点群的确定及先导化合物发现
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Regulation and Function of Oral Resident Memory T Cells
口腔驻留记忆 T 细胞的调节和功能
- 批准号:
10896496 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Defining tissue specific phenotypes that faithfully identify tissue resident memory T cells
定义忠实识别组织驻留记忆 T 细胞的组织特异性表型
- 批准号:
10460129 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Regulation and Function of Oral Resident Memory T Cells
口腔驻留记忆 T 细胞的调节和功能
- 批准号:
10436381 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Ultra-Long-Acting Polymeric Injectable Multi-Purpose Prevention Technology for Contraception and HIV Prevention
用于避孕和艾滋病毒预防的超长效聚合物注射多用途预防技术
- 批准号:
10258079 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
ORMDL3 Stimulated ICAM1 and RVA-induced Childhood Asthma Exacerbations
ORMDL3 刺激 ICAM1 和 RVA 诱导的儿童期哮喘加重
- 批准号:
10369612 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别: